Back

Cumulative LDL-cholesterol exposure after Index percutaneous coronary intervention and subsequent major adverse cardiac and cerebrovascular events

28 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Lp(a), triglycerides and coronary artery disease Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Shigetaka KAGEYAMA

Shizuoka City Hospital, Shizuoka (Japan)

5 More presentations in this session

Presentation thumbnail
Sex-specific differences in lipoprotein (a) levels and their shared impact on coronary artery disease extent in ACS
Doctor F. Buendia Santiago (Cartagena, ES)
Abstract Slides
Presentation thumbnail
Insulin resistance surpasses remnant cholesterol: the triglyceride–glucose index as a stronger predictor of coronary artery disease
Doctor F. Sousa (Funchal, PT)
Abstract Slides
Presentation thumbnail
Transient surge, persistent risk: longitudinal changes in lipoprotein(a) following acute coronary syndrome
Doctor K. Mahajan (Mandi, IN)
Abstract Slides
Presentation thumbnail
Lipoprotein(a) adds no predictive value for coronary disease beyond traditional risk factors
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Remnant cholesterol: an independent determinant of coronary artery disease and future cardiovascular events beyond traditional risk factors
Doctor F. Sousa (Funchal, PT)
Abstract Slides

Access the full session

Session thumbnail
Lp(a), triglycerides and coronary artery disease

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
LDL treatment-years: a new paradigm for cardiovascular risk reduction
1 September 2025
thumbnail
Congress Presentation
Cumulative plaque burden analysis for phenotyping epicardial coronary artery disease
29 August 2025
thumbnail
Congress Presentation
Prognostic significance of elevated lipoprotein(a) in long-term outcomes after PCI with drug-eluting stents
31 August 2025
thumbnail
Congress Presentation
Risk factors control, remnant cholesterol, recurrent events and risk in patients with coronary heart disease. Our experiences
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources